Bench to Bed

Data sharing and individual participant data

Everything filed under system in our medical research coverage, the 8 reports filed on it so far.

Health: An investigational, remote-controlled artificial urinary sphincter is being tested in a 140-patient U.S

Remote-Controlled Artificial Sphincter Enters U.S. Trial

An investigational, remote-controlled artificial urinary sphincter is being tested in a 140-patient U.S. and French study for men with incontinence...

2026-09-20
The FDA has postponed its approval decision for Exelixis' oral kinase inhibitor zanzalintinib in metastatic colorectal...

FDA delays Exelixis' zanzalintinib decision to March 2027

The FDA has postponed its approval decision for Exelixis' oral kinase inhibitor zanzalintinib in metastatic colorectal cancer, requesting updated...

2026-09-12
Health: Novo Nordisk has discontinued two late-stage heart failure trials for its drug ziltivekimab after a data review

Novo Nordisk ends two more phase 3 trials

Novo Nordisk has discontinued two late-stage heart failure trials for its drug ziltivekimab after a data review.

2026-09-07
Health: A new Commonwealth Fund report details a sharp decline in U.S

U.S. Overdose Deaths Drop 27% in 2024

A new Commonwealth Fund report details a sharp decline in U.S. drug overdose deaths in 2024, with preliminary 2025 data showing a continued drop.

2026-09-03
UniQure has submitted AMT-130, a gene therapy for Huntington's disease, to the FDA for accelerated approval based on...

UniQure Seeks FDA Approval for Huntington's Gene Therapy

UniQure has submitted AMT-130, a gene therapy for Huntington's disease, to the FDA for accelerated approval based on three-year data showing it can...

2026-09-02
Verily Health, with NVIDIA and the NIH All of Us program, developed a foundation model combining EHR and genomic data

Verily-NIH multimodal AI model boosts Type 2 diabetes risk detection

Verily Health, with NVIDIA and the NIH All of Us program, developed a foundation model combining EHR and genomic data. The model's performance for...

2026-08-31
Health: Akeso’s CEO highlights a phase-3 success in biliary tract cancer while defending the drug’s data amid NSCLC concerns

Akeso’s Biliary Tract Win Shows ivonescimab Beyond Lung Cancer

Akeso’s CEO highlights a phase-3 success in biliary tract cancer while defending the drug’s data amid NSCLC concerns.

2026-08-26
The use of wearable devices to track health metrics is being promoted by health insurance companies and the Department of...

Health Insurance Companies and MAHA Promote Wearable Surveillance, Raising Ethical Concerns

The use of wearable devices to track health metrics is being promoted by health insurance companies and the Department of Health and Human Services...

2026-08-17